Editorial: Advances in Autoimmune Myasthenia Gravis

[1]  J. Howard,et al.  Imbalance in T follicular helper cells producing IL-17 promotes pro-inflammatory responses in MuSK antibody positive myasthenia gravis , 2020, Journal of Neuroimmunology.

[2]  A. Marx,et al.  Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial , 2019, The Lancet Neurology.

[3]  A. Marx,et al.  MicroRNA and mRNA expression associated with ectopic germinal centers in thymus of myasthenia gravis , 2018, PloS one.

[4]  R. Mantegazza,et al.  Myasthenia gravis: from autoantibodies to therapy , 2018, Current opinion in neurology.

[5]  F. Bolgert,et al.  Regulatory B cells in myasthenia gravis are differentially affected by therapies , 2018, Annals of clinical and translational neurology.

[6]  A. Punga,et al.  Advances in autoimmune myasthenia gravis management , 2018, Expert review of neurotherapeutics.

[7]  Nadine Dragin,et al.  Thymus involvement in early‐onset myasthenia gravis , 2018, Annals of the New York Academy of Sciences.

[8]  A. Cumano,et al.  Estrogen-mediated downregulation of AIRE influences sexual dimorphism in autoimmune diseases. , 2016, The Journal of clinical investigation.

[9]  M. Foti,et al.  Both Treg cells and Tconv cells are defective in the Myasthenia gravis thymus: roles of IL-17 and TNF-α. , 2014, Journal of autoimmunity.

[10]  A. Marx,et al.  The different roles of the thymus in the pathogenesis of the various myasthenia gravis subtypes. , 2013, Autoimmunity reviews.

[11]  H. Garchon,et al.  Genetic Factors in Autoimmune Myasthenia Gravis , 2008, Annals of the New York Academy of Sciences.

[12]  H. Weiner.  Induction of oral tolerance to the acetylcholine receptor for treatment of myasthenia gravis. , 1999, The Journal of clinical investigation.